1. P149 Novel capillary blood point-of-care test for adalimumab and infliximab trough levels: Effects of abnormal blood conditions on the test result. (30th January 2023) Authors: Brosi, L; Reinhard, C; Anchling, L; Afonso, J; Schuster, T; Gerhold, C B; Ricken, B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P153 Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum. (25th January 2019) Authors: Ricken, B; Schneider, M; Bantleon, F; Velayutham, S; Trapani, D; Afonso, J; Magro, F; Abel, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P202 Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum. (25th January 2019) Authors: Bantleon, F; Schneider, M; Ricken, B; Velayutham, S; Trapani, D; Afonso, J; Magro, F; Abel, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P229 Standardization of Quantum Blue® rapid TDM assays with WHO international standards for adalimumab and infliximab. (27th May 2021) Authors: Afonso, J; Ricken, B; Schuster, T; Guschin, D; Schneider, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗